Age (years) |
65.7 ± 13.3 |
64.7 ± 13.8 |
69.4 ± 11.2 |
0.29 |
Male, n (%) |
38 (71.7) |
30 (71.4) |
8 (72.7) |
0.93 |
Use of vasoactive drugs |
35 (66.0) |
27 (64.3) |
8 (72.7) |
0.60 |
Norepinephrine, n (%) |
34 (64.2) |
26 (61.9) |
8 (72.7) |
0.51 |
Epinephrine, n (%) |
6 (11.3) |
5 (11.9) |
1 (9.10) |
0.79 |
Vasopressin, n (%) |
12 (22.6) |
8 (19.1) |
4 (36.5) |
0.22 |
Mechnical ventilation, n (%) |
44 (83.2) |
35 (83.3) |
9 (81.8) |
0.91 |
Renal replacement therapy, n (%) |
14 (26.4) |
11 (26.2) |
3 (27.3) |
0.94 |
Physical examinations |
|
|
|
|
Temperature (°C)
|
38.7 ± 0.37
|
38.8 ± 0.39
|
38.6 ± 0.21
|
0.10
|
Systolic blood pressure (mmHg)
|
86.4 ±17.6
|
88.4 ±15.7
|
78.6 ± 22.8
|
0.11
|
Diastolic blood pressure (mmHg)
|
44.2 ± 9.57
|
46.4 ± 8.10
|
41.5 ± 7.88
|
0.09
|
Complete blood counts and blood biochemistry |
|
|
|
|
Platelet counts, median (IQR) ×109/L
|
61.2 (54.4 -93.4)
|
83.0 (63.5 - 108.5)
|
40.3 (15.7 - 103.6)
|
0.12
|
White blood cell, median (IQR) ×109/L
|
10.1 (7.72 -13.3)
|
10.5 (8.19 - 13.3)
|
8.99 (3.02 - 26.7)
|
0.77
|
C reactive protein (mg/L), median (IQR)
|
152.1 (125.0 - 185.1)
|
140.6 (110.4-179.1)
|
204.4 (150.4 -277.8)
|
0.06
|
Procalcitonin (pg/L), median (IQR)
|
4.84 (3.04 - 7.72)
|
3.70 (2.20 - 6.21)
|
12.9 (4.13 - 40.4)
|
0.03
|
Serum creatinine (μmol/L), median (IQR)
|
125.6 (107.2 -147.1)
|
119.2 (98.9 - 143.6)
|
151.5 (103.9 - 220.9)
|
0.22
|
Serum lactate (mmol/L), median (IQR)
|
3.01 (2.50 - 3.62)
|
2.76 (2.28 -3.43)
|
4.26 (2.75 -6.89)
|
0.04
|
SOFA score |
11.2 ± 4.77 |
10.5 ± 4.54 |
13.8 ± 4.85 |
0.03 |
APACHE II score |
23.2 ± 7.46 |
21.9 ± 6.63 |
27.9 ± 8.77 |
0.02 |
28 - day mortality, n (%) |
34 (64.2) |
24 (70.6) |
10 (90.1) |
0.04 |